Apogee Therapeutics

Last updated: July 11, 2025

CEO Michael Henderson
CEO Michael Henderson
USA | Funding: $652M (+)

Website: http://www.apogeetherapeutics.com/

Apogee Therapeutics operates pipeline candidates designed to treat inflammatory and immunological disorders.

Promote Startup